[Treatment of vulvovaginitis with a new preparation with polyvalent action].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001147:Arsanilic Acid / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D004129:Dimethylpolysiloxanes / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use*; D009761:Nystatin / Q000627:therapeutic use*; D011112:Polymyxin B / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D012828:Silicones / Q000627:therapeutic use*; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D002575:Uterine Cervicitis / Q000188:drug therapy; D014848:Vulvovaginitis / Q000188:drug therapy*
D001152:Arsenicals; D004129:Dimethylpolysiloxanes; D004338:Drug Combinations; D011113:Polymyxins; D012828:Silicones; D009761:Nystatin; D009355:Neomycin; D011112:Polymyxin B; D001147:Arsanilic Acid
Sul trattamento delle vulvovaginiti con un nuovo preparato ad attività polivalente.